Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data
暂无分享,去创建一个
C. Hermans | G. Dolan | C. Rothschild | H. Chambost | R. Klamroth | C. Altisent | R. Lassila | A. Batorova | M. Richards | P. de Moerloose | A. Karafoulidou | M. Fraga | A. Bátorová
[1] M. Makris,et al. Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.
[2] K. Fischer,et al. Can long‐term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the Netherlands , 2005, British journal of haematology.
[3] Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.
[4] D. Grobbee,et al. Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.
[5] Mannucci,et al. Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy , 2000, Haemophilia : the official journal of the World Federation of Hemophilia.
[6] J. Bijlsma,et al. Articular cartilage is more susceptible to blood induced damage at young than at old age. , 2000, The Journal of rheumatology.
[7] C. Kessler,et al. Guidelines on treatment of haemophilia in Sweden , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.
[8] Jurgutis,et al. The Malmö–Klaipeda WFH twinning programme: a comparative description of the Haemophilia cohorts , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.